全文获取类型
收费全文 | 248097篇 |
免费 | 18978篇 |
国内免费 | 7838篇 |
专业分类
耳鼻咽喉 | 1520篇 |
儿科学 | 7813篇 |
妇产科学 | 3466篇 |
基础医学 | 21345篇 |
口腔科学 | 4334篇 |
临床医学 | 25832篇 |
内科学 | 57573篇 |
皮肤病学 | 3012篇 |
神经病学 | 27897篇 |
特种医学 | 7908篇 |
外国民族医学 | 10篇 |
外科学 | 21260篇 |
综合类 | 34663篇 |
现状与发展 | 33篇 |
一般理论 | 9篇 |
预防医学 | 20645篇 |
眼科学 | 2516篇 |
药学 | 16887篇 |
203篇 | |
中国医学 | 11403篇 |
肿瘤学 | 6584篇 |
出版年
2024年 | 745篇 |
2023年 | 4996篇 |
2022年 | 9121篇 |
2021年 | 12921篇 |
2020年 | 12026篇 |
2019年 | 9145篇 |
2018年 | 9190篇 |
2017年 | 9149篇 |
2016年 | 9532篇 |
2015年 | 9204篇 |
2014年 | 17643篇 |
2013年 | 18838篇 |
2012年 | 14535篇 |
2011年 | 15735篇 |
2010年 | 12559篇 |
2009年 | 12014篇 |
2008年 | 11850篇 |
2007年 | 11543篇 |
2006年 | 10188篇 |
2005年 | 8415篇 |
2004年 | 7132篇 |
2003年 | 6110篇 |
2002年 | 5167篇 |
2001年 | 4480篇 |
2000年 | 3741篇 |
1999年 | 3195篇 |
1998年 | 3011篇 |
1997年 | 2671篇 |
1996年 | 2368篇 |
1995年 | 2177篇 |
1994年 | 1965篇 |
1993年 | 1706篇 |
1992年 | 1610篇 |
1991年 | 1402篇 |
1990年 | 1114篇 |
1989年 | 950篇 |
1988年 | 892篇 |
1987年 | 816篇 |
1986年 | 719篇 |
1985年 | 858篇 |
1984年 | 711篇 |
1983年 | 424篇 |
1982年 | 502篇 |
1981年 | 425篇 |
1980年 | 320篇 |
1979年 | 279篇 |
1978年 | 210篇 |
1977年 | 181篇 |
1976年 | 156篇 |
1975年 | 64篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
31.
32.
33.
Jennifer Wang Jonathan G. Stine Scott L. Cornella Curtis K. Argo Steven M. Cohn 《临床与转化肝病杂志(英文版)》2015,3(4):254-259
Background and Aims: Gastric antral vascular ectasia (GAVE) is commonly found in patients with cirrhosis, but it is also associated with other diseases in the absence of cirrhosis. Whether GAVE confers a different severity of gastrointestinal (GI) bleeding between patients with and without cirrhosis remains unknown. We aim to examine whether there is a difference in clinically significant GI bleeding due to GAVE in patients with or without cirrhosis. Methods: This is a retrospective case-control study of patients who were diagnosed with GAVE between January 2000 and June 2014. Patients were categorized into cirrhosis and noncirrhosis groups, and those with an additional GI bleeding source were excluded. Univariate comparisons and multivariable models were constructed using logistic regression. Results: In total, 110 patients diagnosed with GAVE on esophagogastroduodenoscopy (EGD) were included in our analysis; 84 patients had cirrhosis (76.4%) and 26 (23.6%) did not. Active GI bleeding was more prevalent in patients without cirrhosis (63.4% vs. 32.1%, p=0.003) despite similar indications for EGD, and endoscopic treatment with argon plasma coagulation (APC) was required more often in this group, approaching statistical significance (27% vs. 10.7%, p=0.056). There was no difference in bleeding severity, as evidenced by similar re-bleeding rates, surgery, or death attributed to uncontrolled bleeding. The strongest independent risk factor for GI bleeding was the absence of cirrhosis (odds ratio (OR): 5.151 (95% confidence interval (CI): 1.08-24.48, p=0.039). Conclusions: Patients with GAVE in the absence of cirrhosis are at higher risk for active GI bleeding and require more frequent endoscopic treatment than similar patients with cirrhosis. It may be worthwhile to treat GAVE in this population even in the absence of active bleeding. 相似文献
34.
35.
Sequential Therapy Based on Evolvement of Patterns: A New Model for Treatment of Alzheimer’s Disease
In order to solve the problem of long-term (>9 months) efficacy in the treatment of Alzheimer''s disease (AD) by conventional therapy (CT), a staged and multiply-targeted sequential therapy based on the evolvement of patterns (STEP) was developed. Its main innovations include: (1) the time order of evolution of patterns defined by Chinese medicine (CM) in AD was found, that is, "the orderly pattern evolution starting from Shen (Kidney) deficiency, progressing to phlegm, stasis and fire, and worsening to severe toxin as well as functional collapse"; (2) the cascade hypothesis of Shen deficiency in AD and its sequential therapy based on Shen-reinforcing was proposed, that is, "reinforcing Shen in the early stage and throughout the whole process, resolving phlegm, activating blood and purging fire in the middle stage, detoxifying and replenishing vitality to stop the collapse in the advanced stage", and through meta-analysis, clinical drug use was optimized, thus the leap from "inferential selection" to "evidence-based selection" was realized; (3) the STEP regimen combined with CT maintained cognitive and behavioral stability in AD patients for at least 12 months, with cognitive enhancement and behavioral synergy after 9 months, and cognitive benefit was superior to CT at 9, 12, 15, 18, 21, and 24 months, respectively. The 2-year cognitive improvement rate was increased by 25.64% (P=0.020) and the cognitive deterioration rate was decreased by 48.71% (P=0.000). Among them, the cognitive and functional benefits of Shen-reinforcing therapy for very early AD (350 cases) for 1 year were better than the placebo (P<0.001), and the dementia conversion rate was reduced by 8.85% (P=0.002). The behavioral symptomatic relief of patients with vascular dementia received fire-purging therapy (540 cases) was superior to those received CT (P=0.016). These data suggested that the STEP regimen has synergistic effects on CTs at least in terms of cognitive benefit, and the earlier the use, the greater the benefit will have. Therefore, the STEP regimen should be considered as one of the clinical options, particularly for the dearth of effective pharmaceutical or immunological interventions that are currently available for AD. 相似文献
36.
About 10% of patients with Lyme disease continue to experience musculoskeletal pain and cognitive dysfunction after recommended antibiotic treatment. This condition is called post-Lyme disease syndrome (PLDS) or post-treatment Lyme disease syndrome. These two terms are used interchangeably. The pathogenesis of PLDS has been controversial. The hypothesis that patients with PLDS may harbor hidden reservoirs of Borrelia burgdorferi after their initial antibiotic treatment is difficult to accept. The prospective, double-blind studies contradict this point of view. Also, recently published research applying xenodiagnosis to PLDS supports the opinion that PLDS most likely has an autoimmune background. Lengthy courses of antibiotics are not justified in patients with PLDS because of the lack of benefit, and they are fraught with hazards. Most patients with PLDS recover from persistent symptoms with time. However, it can take months before they feel completely well. 相似文献
37.
38.
39.
40.
K.-C. Sung D.-C. Seo S.-J. Lee M.-Y. Lee S.H. Wild C.D. Byrne 《Nutrition, metabolism, and cardiovascular diseases : NMCD》2019,29(5):489-495